Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Recommendations for participation in competitive sport in athletes with hypertrophic cardiomyopathy: opening the sacks of Aeolus.

Pagourelias ED, Kouidi E, Vassilikos VP.

Eur Heart J. 2019 Jul 10. pii: ehz475. doi: 10.1093/eurheartj/ehz475. [Epub ahead of print] No abstract available.

PMID:
31292626
2.

Understanding the Beat-to-Beat Variations of P-Waves Morphologies in AF Patients During Sinus Rhythm: A Scoping Review of the Atrial Simulation Studies.

Filos D, Tachmatzidis D, Maglaveras N, Vassilikos V, Chouvarda I.

Front Physiol. 2019 Jun 18;10:742. doi: 10.3389/fphys.2019.00742. eCollection 2019. Review.

3.

Iron deficiency as therapeutic target in heart failure: a translational approach.

Bakogiannis C, Briasoulis A, Mouselimis D, Tsarouchas A, Papageorgiou N, Papadopoulos C, Fragakis N, Vassilikos V.

Heart Fail Rev. 2019 Jun 22. doi: 10.1007/s10741-019-09815-z. [Epub ahead of print] Review.

PMID:
31230175
4.

GDF-15 as a risk stratification biomarker for cardiovascular disease.

Tzikas S, Vassilikos V, Keller T.

Int J Cardiol. 2019 Oct 1;292:246-247. doi: 10.1016/j.ijcard.2019.06.009. Epub 2019 Jun 8. No abstract available.

PMID:
31204068
5.

Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.

Gatzoulis KA, Tsiachris D, Arsenos P, Antoniou CK, Dilaveris P, Sideris S, Kanoupakis E, Simantirakis E, Korantzopoulos P, Goudevenos I, Flevari P, Iliodromitis E, Sideris A, Vassilikos V, Fragakis N, Trachanas K, Vernardos M, Konstantinou I, Tsimos K, Xenogiannis I, Vlachos K, Saplaouras A, Triantafyllou K, Kallikazaros I, Tousoulis D.

Eur Heart J. 2019 May 3. pii: ehz260. doi: 10.1093/eurheartj/ehz260. [Epub ahead of print]

PMID:
31049557
6.

Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers.

Kyriakou P, Mouselimis D, Tsarouchas A, Rigopoulos A, Bakogiannis C, Noutsias M, Vassilikos V.

BMC Cardiovasc Disord. 2018 Dec 4;18(1):221. doi: 10.1186/s12872-018-0952-8.

7.

Arterial adaptations in athletes of dynamic and static sports disciplines - a pilot study.

Sotiriou P, Kouidi E, Karagiannis A, Koutlianos N, Geleris P, Vassilikos V, Deligiannis A.

Clin Physiol Funct Imaging. 2019 May;39(3):183-191. doi: 10.1111/cpf.12554. Epub 2018 Nov 11.

PMID:
30417605
8.

Impact of Radiofrequency Ablation and Antiarrhythmic Medications on the Quality of Life of Patients with Supraventricular Tachycardias: Preliminary Validation of the Greek Version of the Umea22 (U22) Questionnaire.

Domeyer PR, Giannakidou SC, Kyriakou P, Katsari V, Antoniadis AP, Lagos IK, Fragakis N, Varaklioti A, Vassilikos VP.

Biomed Res Int. 2018 Oct 9;2018:3059478. doi: 10.1155/2018/3059478. eCollection 2018.

9.

Left atrial voltage mapping using a new impedance-based algorithm in patients with paroxysmal atrial fibrillation.

Asvestas D, Vlachos K, Bazoukis G, Martin CA, Letsas KP, Sakellaropoulou A, Kossyvakis C, Saplaouras A, Prappa E, Goga C, Vassilikos V, Valkanas K, Deftereos S, Sideris A, Efremidis M.

Pacing Clin Electrophysiol. 2018 Nov;41(11):1447-1453. doi: 10.1111/pace.13501. Epub 2018 Oct 3.

PMID:
30225845
10.

Relation of regional myocardial structure and function in hypertrophic cardiomyopathy and amyloidois: a combined two-dimensional speckle tracking and cardiovascular magnetic resonance analysis.

Pagourelias ED, Mirea O, Vovas G, Duchenne J, Michalski B, Van Cleemput J, Bogaert J, Vassilikos VP, Voigt JU.

Eur Heart J Cardiovasc Imaging. 2019 Apr 1;20(4):426-437. doi: 10.1093/ehjci/jey107.

PMID:
30085025
11.

Transcarotid approach for TAVI: Presentation of a challenging case.

Tzikas S, Bompotis G, Sarantzis N, Toutouzas K, Lazaridis I, Styliadis I, Tousoulis D, Vassilikos V.

Hellenic J Cardiol. 2019 Jan - Feb;60(1):64-65. doi: 10.1016/j.hjc.2018.04.007. Epub 2018 May 5. No abstract available.

12.

Left atrial deformation as a potent predictor for paroxysmal atrial fibrillation in patients with end-stage renal disease.

Papadopoulos CE, Pagourelias E, Bakogiannis C, Triantafyllou K, Baltoumas K, Kassimatis E, Zioutas D, Siskos D, Tzikas S, Fragakis N, Papagianni A, Vassilikos V.

Int J Cardiovasc Imaging. 2018 Sep;34(9):1393-1401. doi: 10.1007/s10554-018-1353-x. Epub 2018 Apr 21.

PMID:
29680911
13.

PRRX1 Rs3903239 polymorphism and atrial fibrillation in a Greek population.

Kalinderi K, Fragakis N, Sotiriadou M, Oriol DI, Katritsis D, Letsas K, Korantzopoulos P, Karamanolis A, Pagourelias E, Antoniadis AP, Dalampyras P, Mavroudi M, Kyriakou P, Papadopoulos C, Skeberis V, Vassilikos V, Fidani L.

Hellenic J Cardiol. 2018 Sep - Oct;59(5):298-299. doi: 10.1016/j.hjc.2018.01.005. Epub 2018 Jan 31. No abstract available.

14.

Electrophysiological markers predicting impeding AV-block during ablation of atrioventricular nodal reentry tachycardia.

Fragakis N, Krexi L, Kyriakou P, Sotiriadou M, Lazaridis C, Karamanolis A, Dalampyras P, Tsakiroglou S, Skeberis V, Tsalikakis D, Vassilikos V.

Pacing Clin Electrophysiol. 2018 Jan;41(1):7-13. doi: 10.1111/pace.13245. Epub 2017 Dec 28.

PMID:
29194653
15.

Coincidental ganglionated plexus modification during radiofrequency pulmonary vein isolation and post-ablation arrhythmia recurrence.

Giannopoulos G, Kossyvakis C, Angelidis C, Panagopoulou V, Tsiachris D, Vrachatis DA, Doudoumis K, Letsas K, Pagoni S, Stefanadis C, Vassilikos VP, Lekakis J, Deftereos S.

Europace. 2017 Dec 1;19(12):1967-1972. doi: 10.1093/europace/euw309.

PMID:
29194518
16.

Transvenous lead extraction: Can it be simple yet safe?

Antoniadis AP, Vassilikos VP.

Anatol J Cardiol. 2017 Oct;18(4):296-297. doi: 10.14744/AnatolJCardiol.2017.25858. No abstract available.

17.

Beat-to-beat P-wave morphology as a predictor of paroxysmal atrial fibrillation.

Filos D, Chouvarda I, Tachmatzidis D, Vassilikos V, Maglaveras N.

Comput Methods Programs Biomed. 2017 Nov;151:111-121. doi: 10.1016/j.cmpb.2017.08.016. Epub 2017 Aug 24.

PMID:
28946993
18.

Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase.

Proietti M, Laroche C, Nyvad O, Haberka M, Vassilikos VP, Maggioni AP, Boriani G, Lip GYH; EORP-AF Pilot Investigators.

Int J Cardiol. 2017 Dec 1;248:166-172. doi: 10.1016/j.ijcard.2017.08.055. Epub 2017 Aug 26.

PMID:
28859841
19.

GDF-15 predicts cardiovascular events in acute chest pain patients.

Tzikas S, Palapies L, Bakogiannis C, Zeller T, Sinning C, Baldus S, Bickel C, Vassilikos V, Lackner KJ, Zeiher A, Münzel T, Blankenberg S, Keller T.

PLoS One. 2017 Aug 3;12(8):e0182314. doi: 10.1371/journal.pone.0182314. eCollection 2017.

20.

Electrical storm in a patient with Duchenne muscular dystrophy cardiomyopathy triggered by abrupt β-blocker interruption.

Fragakis N, Sotiriadou M, Krexi L, Vassilikos V.

Ann Noninvasive Electrocardiol. 2017 Nov;22(6). doi: 10.1111/anec.12477. Epub 2017 Jun 15.

PMID:
28618061
21.

Diagnosis of tuberous sclerosis complex in a patient referred for uncontrolled hypertension and renal dysfunction: a case highlighting the importance of proper diagnostic work-up of hypertensive patients.

Sarafidis PA, Bikos A, Loutradis C, Tzikas S, Vakirlis E, Avdelidou E, Zafeiriou D, Papagianni A, Vassilikos V.

J Hypertens. 2017 Oct;35(10):2109-2114. doi: 10.1097/HJH.0000000000001423.

PMID:
28594706
22.

"Real life" longevity of implantable cardioverter-defibrillator devices.

Manolis AS, Maounis T, Koulouris S, Vassilikos V.

Clin Cardiol. 2017 Sep;40(9):759-764. doi: 10.1002/clc.22729. Epub 2017 May 22.

23.

A Case of a Paracardial Osteophyte Causing Atrial Compression.

Tzikas S, Triantafyllou K, Papadopoulos C, Vassilikos V.

Case Rep Med. 2016;2016:4325830. doi: 10.1155/2016/4325830. Epub 2016 Dec 29.

24.

Successful catheter ablation of an incessant ventricular tachycardia originating from the posterior papillary muscle in a structurally normal right ventricle.

Fragakis N, Karamitsos TD, Vassilikos V.

Hellenic J Cardiol. 2016 Aug 20. pii: S1109-9666(16)30154-3. doi: 10.1016/j.hjc.2016.05.007. [Epub ahead of print] No abstract available.

25.

Diastolic dysfunction is associated with low urinary sodium excretion in patients with decompensated cirrhosis.

Cholongitas E, Goulis I, Pagourelias E, Birtsou C, Ioannidou M, Ioannidou M, Chalevas P, Soulaidopoulos S, Vassilikos V, Akriviadis E.

Ann Hepatol. 2016 Sep-Oct;15(5):545-751. doi: 10.5604/16652681.1212534.

26.

A Left Atrial Appendage Phantom Structure.

Papadopoulos CE, Fotoglidis A, Pagourelias E, Vassilikos V.

J Cardiovasc Ultrasound. 2016 Jun;24(2):172-3. doi: 10.4250/jcu.2016.24.2.172. Epub 2016 Jun 22. No abstract available.

27.

A Rare Case of Lipomatous Hypertrophy of the Interventricular Septum.

Papadopoulos CE, Matsiras S, Vassilikos V.

J Cardiovasc Ultrasound. 2016 Jun;24(2):170-1. doi: 10.4250/jcu.2016.24.2.170. Epub 2016 Jun 22.

28.

Implantable cardioverter defibrillators for primary prevention of sudden death in hypertrophic cardiomyopathy.

Konstantinou DM, Efthimiadis GK, Vassilikos V, Paraskevaidis S, Pagourelias E, Maron BJ, Karvounis H.

J Cardiovasc Med (Hagerstown). 2016 Jun;17(6):433-9. doi: 10.2459/JCM.0000000000000333.

PMID:
26885981
29.

Diastolic dysfunction is associated with low urinary sodium excretion in patients with decompensated cirrhosis.

Cholongitas E, Goulis I, Pagourelias E, Birtsou C, Loannidou M, Chalevas P, Soulaidopoulos S, Vassilikos V, Akriviadis E.

Ann Hepatol. 2016 Sep - Oct;15(5):745-751. doi: 10.5604/16652681.1212542.

30.

Altered Calcium Handling in Reperfusion Injury.

Bompotis GC, Deftereos S, Angelidis C, Choidis E, Panagopoulou V, Kaoukis A, Vassilikos VP, Cleman MW, Giannopoulos G.

Med Chem. 2016;12(2):114-30. Review.

PMID:
26411605
31.

Intra--and Intercellular Calcium Handling in Pulmonary Arterial Hypertension.

Mouratoglou SA, Giannakoulas G, Deftereos S, Giannopoulos G, Angelidis C, Cleman MW, Vassilikos VP.

Med Chem. 2016;12(2):162-9. Review.

PMID:
26411601
32.

P wave analysis with wavelets identifies hypertensive patients at risk of recurrence of atrial fibrillation: A case-control study and 1year follow-up.

Dakos G, Konstantinou D, Chatzizisis YS, Chouvarda I, Filos D, Paraskevaidis S, Mantziari L, Maglaveras N, Karvounis H, Vassilikos V.

J Electrocardiol. 2015 Sep-Oct;48(5):845-52. doi: 10.1016/j.jelectrocard.2015.07.012. Epub 2015 Jul 14.

PMID:
26216370
33.

Left ventricular outflow obstruction secondary to accessory mitral valve tissue in a patient with hypertrophic cardiomyopathy.

Papadopoulos CE, Pagourelias E, Kallifatidis A, Zioutas D, Vassilikos V.

J Echocardiogr. 2015 Jun;13(2):79-80. doi: 10.1007/s12574-015-0247-3. Epub 2015 May 21. No abstract available.

PMID:
26184644
34.

Left Ventricular Myocardial Mechanics in Cirrhosis: A Speckle Tracking Echocardiographic Study.

Pagourelias ED, Sotiriou P, Papadopoulos CE, Cholongitas E, Giouleme O, Vassilikos V.

Echocardiography. 2016 Feb;33(2):223-32. doi: 10.1111/echo.13010. Epub 2015 Jul 14.

PMID:
26174780
35.

Association Between rs2200733 Polymorphism on Chromosome 4q25 and Atrial Fibrillation in a Greek Population.

Kalinderi K, Fragakis N, Koskinas KC, Katritsis D, Letsas K, Efremidis M, Korantzopoulos P, Rossios K, Pagourelias E, Giannakopoulou P, Mavroudi M, Kyriakou P, Skeberis V, Geleris P, Vassilikos V, Fidani L.

Hellenic J Cardiol. 2015 May-Jun;56(3):224-9.

36.

Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation.

Giannopoulos G, Kossyvakis C, Angelidis C, Efremidis M, Panagopoulou V, Letsas K, Bouras G, Vassilikos VP, Goudevenos J, Tousoulis D, Lekakis J, Deftereos S.

Heart Rhythm. 2015 Jul;12(7):1470-5. doi: 10.1016/j.hrthm.2015.04.002. Epub 2015 Apr 3.

PMID:
25847478
37.

Endocarditis caused by unusual Streptococcus species (Streptococcus pluranimalium).

Fotoglidis A, Pagourelias E, Kyriakou P, Vassilikos V.

Hippokratia. 2015 Apr-Jun;19(2):182-5.

38.

The use of adenosine and adenosine triphosphate testing in the diagnosis, risk stratification and management of patients with syncope: current evidence and future perspectives.

Fragakis N, Antoniadis AP, Saviano M, Vassilikos V, Pappone C.

Int J Cardiol. 2015 Mar 15;183:267-73. doi: 10.1016/j.ijcard.2015.01.089. Epub 2015 Jan 30. Review.

PMID:
25725201
39.

Ranolazine as a promising treatment option for atrial fibrillation: electrophysiologic mechanisms, experimental evidence, and clinical implications.

Fragakis N, Koskinas KC, Vassilikos V.

Pacing Clin Electrophysiol. 2014 Oct;37(10):1412-20. doi: 10.1111/pace.12486. Epub 2014 Aug 19. Review.

PMID:
25138058
40.

Survival with cardiac-resynchronization therapy.

Pagourelias ED, Efthimiadis GK, Vassilikos V.

N Engl J Med. 2014 Jul 31;371(5):477. doi: 10.1056/NEJMc1407182. No abstract available.

PMID:
25075843
41.

Percutaneous extraction of transvenous permanent pacemaker/defibrillator leads.

Paraskevaidis S, Konstantinou D, Vassilikos V, Theofilogiannakos E, Mantziari L, Megarisiotou A, Galitsianos I, Karvounis C.

Biomed Res Int. 2014;2014:949785. doi: 10.1155/2014/949785. Epub 2014 May 26.

42.

Pseudoaneurysm of the non-coronary sinus of Valsalva mimicking an interatrial septal mass.

Karamitsos TD, Vourvouri E, Kallifatidis A, Karvounis H, Vassilikos V.

Eur Heart J Cardiovasc Imaging. 2014 Oct;15(10):1182. doi: 10.1093/ehjci/jeu093. Epub 2014 May 27. No abstract available.

PMID:
24866898
43.

Wavelet-based analysis of P waves identifies patients with lone atrial fibrillation: a cross-sectional pilot study.

Dakos G, Chatzizisis YS, Konstantinou D, Chouvarda I, Filos D, Paraskevaidis S, Mantziari L, Maglaveras N, Karvounis H, Styliadis I, Vassilikos V.

Int J Cardiol. 2014 Jun 15;174(2):389-92. doi: 10.1016/j.ijcard.2014.03.195. Epub 2014 Apr 6. No abstract available.

PMID:
24767760
44.

Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation.

Koskinas KC, Fragakis N, Katritsis D, Skeberis V, Vassilikos V.

Europace. 2014 Jul;16(7):973-9. doi: 10.1093/europace/eut407. Epub 2014 Jan 27.

PMID:
24473502
45.

A de novo novel cardiac ryanodine mutation (Ser4155Tyr) associated with catecholaminergic polymorphic ventricular tachycardia.

Mantziari L, Vassilikos V, Anastasakis A, Kotsaka X, Paraskevaidis S, Styliadis IH, Luria D.

Ann Noninvasive Electrocardiol. 2013 Nov;18(6):571-6. doi: 10.1111/anec.12089. Epub 2013 Oct 23.

PMID:
24147812
46.

Quinidine: an "endangered species" drug appropriate for management of electrical storm in brugada syndrome.

Paraskevaidis S, Theofilogiannakos EK, Kamperidis V, Chatzizisis YS, Tsilonis K, Vassilikos VP, Dakos G, Stavropoulos G, Ziakas A, Hadjimiltiades S, Styliadis IH.

Indian Pacing Electrophysiol J. 2013 Sep 1;13(5):178-80. eCollection 2013.

47.

Two dimensional wavelet energy analysis on a beat to beat basis: application to Atrial Fibrillation.

Filos D, Chouvarda I, Dakos G, Vassilikos V, Maglaveras N.

Conf Proc IEEE Eng Med Biol Soc. 2013;2013:3793-6. doi: 10.1109/EMBC.2013.6610370.

PMID:
24110557
48.

QRS analysis using wavelet transformation for the prediction of response to cardiac resynchronization therapy: a prospective pilot study.

Vassilikos VP, Mantziari L, Dakos G, Kamperidis V, Chouvarda I, Chatzizisis YS, Kalpidis P, Theofilogiannakos E, Paraskevaidis S, Karvounis H, Mochlas S, Maglaveras N, Styliadis IH.

J Electrocardiol. 2014 Jan-Feb;47(1):59-65. doi: 10.1016/j.jelectrocard.2013.08.003. Epub 2013 Sep 10.

PMID:
24034302
49.

Right atrial and ventricular adaptations to training in male Caucasian athletes: an echocardiographic study.

Pagourelias ED, Kouidi E, Efthimiadis GK, Deligiannis A, Geleris P, Vassilikos V.

J Am Soc Echocardiogr. 2013 Nov;26(11):1344-52. doi: 10.1016/j.echo.2013.07.019. Epub 2013 Aug 24.

PMID:
23978677
50.

Atypical presentation of the most typical cardiac tumor.

Pagourelias ED, Rossios K, Kyriakou P, Mavroudi M, Tanos D, Vassilikos V.

Herz. 2014 May;39(3):400-2. doi: 10.1007/s00059-013-3832-0. Epub 2013 May 29. No abstract available.

PMID:
23712826

Supplemental Content

Loading ...
Support Center